¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"lymphocyte analysis"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
atypical lymphocyte
ºñÁ¤Çü¸²ÇÁ±¸
effector lymphocyte
È¿°ú¸²ÇÁ±¸
killer lymphocyte
»ìÇØ¸²ÇÁ±¸, ¼¼Æ÷µ¶¼º¸²ÇÁ±¸
lymphocyte
¸²ÇÁ±¸
lymphocyte activating factor
¸²ÇÁ±¸È°¼ºÀÎÀÚ
lymphocyte inhibitory factor
¸²ÇÁ±¸¾ïÁ¦ÀÎÀÚ
lymphocyte series
¸²ÇÁ±¸°è¿
lymphocyte-activating determinant
¸²ÇÁ±¸È°¼º°áÁ¤ÀÎÀÚ
mixed lymphocyte culture
È¥ÇÕ¸²ÇÁ±¸¹è¾ç
mixed lymphocyte culture test
È¥ÇÕ¸²ÇÁ±¸¹è¾ç°Ë»ç
mixed lymphocyte reaction
¸²ÇÁ±¸È¥ÇÕ¹è¾ç¹ÝÀÀ
monocyte lymphocyte ratio
´ÜÇÙ±¸¸²ÇÁ±¸ºñÀ²
primed lymphocyte
ÃÊȸ¹Î°¨¸²ÇÁ±¸
primed lymphocyte typing
ÃÊȸ¹Î°¨¸²ÇÁ±¸Çü°áÁ¤
reticular lymphocyte
±×¹°¸²ÇÁ±¸, ¸Á»ó¸²ÇÁ±¸
´ÙÀ½
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
12
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
mixed lymphocyte culture
È¥ÇÕ¸²ÇÁ±¸¹è¾ç
lymphocyte
¸²ÇÁ±¸
analysis
ºÐ¼®
antigen analysis
Ç׿øºÐ¼®
path analysis
°æ·ÎºÐ¼®
qualitative analysis
Á¤¼ººÐ¼®
quantitative analysis
Á¤·®ºÐ¼®
statistical analysis
Åë°èºÐ¼®
survival analysis
»ýÁ¸ºÐ¼®
system analysis
°èÅëºÐ¼®
meta-analysis
¸ÞŸºÐ¼®
self-analysis
ÀÚ±âºÐ¼®
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
atypical lymphocyte
ºñÀüÇü¸²ÇÁ±¸
lymphocyte-activating determinant
¸²ÇÁ±¸È°¼º°áÁ¤±â
effector lymphocyte
ÀÛµ¿¸²ÇÁ±¸
lymphocyte activating factor
¸²ÇÁ±¸È°¼ºÀÎÀÚ
lymphocyte inhibitory factor
¸²ÇÁ±¸¾ïÁ¦ÀÎÀÚ
killer lymphocyte
¼¼Æ÷µ¶¼º¸²ÇÁ±¸
lymphocyte
¸²ÇÁ±¸
leukocytoid lymphocyte
¹éÇ÷±¸¸ð¾ç¸²ÇÁ±¸
lymphocyte series
¸²ÇÁ±¸°è¿
primed lymphocyte
ÃÊȸ¹Î°¨¸²ÇÁ±¸
resident lymphocyte
»óÁÖ¸²ÇÁ±¸
reticular lymphocyte
¸Á»ó¸²ÇÁ±¸
sensitized lymphocyte
¹Î°¨¸²ÇÁ±¸
short lived lymphocyte
´Ü»ý¸²ÇÁ±¸, ªÀº¼ö¸í¸²ÇÁ±¸
thymic lymphocyte
°¡½¿»ù¸²ÇÁ±¸
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
T cell ; T lymphocyte ; thymus derived lymphocyte
T¼¼Æ÷ ; T¸²ÇÁ? ; Èä¼±À¯·¡¸²ÇÁ?
B cell/lymphocyte
B ¼¼Æ÷/¸²ÇÁ±¸
B lymphocyte
B ¸²ÇÁ±¸
B-lymphocyte
B ¸²ÇÁ±¸.
Bare lymphocyte syndrome
¹«Ç¥Áö¸²ÇÁ±¸ÁõÈıº
T cell/lymphocyte
T ¼¼Æ÷/¸²ÇÁ±¸
T lymphocyte
T ¸²ÇÁ±¸
T-lymphocyte
T-Àӯı¸
anti-lymphocyte globulin
¸²ÇÁ±¸ Çױ۷κҸ°
antigen, lymphocyte defined (LD)
¸²ÇÁ±¸ Ç¥¸éÇ׿ø, LDÇ׿ø
granulocyte-monocyte-lymphocyte antigens
°ú¸³±¸´Ü±¸¸²ÇÁ±¸Ç׿ø
granulocyte-platelet-lymphocyte antigens
°ú¸³±¸Ç÷¼ÒÆÇ¸²ÇÁ±¸Ç׿ø
hodgkins disease,lymphocyte predominance
¸²ÇÁ±¸ ÇöÀúÇü
primed lymphocyte
ÃÊȸ°¨ÀÛ ¸²ÇÁ±¸
primed lymphocyte typing
ÃÊȸÇ׿øÀÚ±ØÈÄ ¸²ÇÁ±¸Çüº°È
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
1
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
lymphocyte analysis
¸²ÇÁ±¸ºÐ¼®
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
anti-lymphocyte globulin
¸²ÇÁ±¸ Çױ۷κҸ°
antigen, lymphocyte defined (LD)
¸²ÇÁ±¸ Ç¥¸éÇ׿ø, LDÇ׿ø
atypical lymphocyte
ÀÌÇü<ºñÁ¤Çü>¸²ÇÁ±¸(?Ë´).
cytotoxic T lymphocyte (CTL)
¼¼Æ÷µ¶¼ºT¸²ÇÁ±¸
effector T lymphocyte
ÀÛµ¿T¸²ÇÁ±¸
effector lymphocyte
ÀÛµ¿¸²ÇÁ±¸.
granulocyte-monocyte-lymphocyte antigens
°ú¸³±¸´Ü±¸¸²ÇÁ±¸Ç׿ø
granulocyte-platelet-lymphocyte antigens
°ú¸³±¸Ç÷¼ÒÆÇ¸²ÇÁ±¸Ç׿ø
hodgkins disease,lymphocyte predominance
¸²ÇÁ±¸ ÇöÀúÇü
killer lymphocyte
»ìÇØ¸²ÇÁ±¸
large lymphocyte
´ë¸²ÇÁ±¸(¡Ï¹).
large lymphocyte
Å«¸²ÇÁ±¸
large lymphocyte
´ë¸²ÇÁ±¸(?Ë´).
leukocytoid lymphocyte
¹éÇ÷±¸¾ç ¸²ÇÁ±¸
lymphocyte
¸²ÇÁ±¸(¡Ï¹).
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
ÅëÇÕ°Ë»ö ¿Ï·á
´ÙÀ½